IRB Determination

Attachment 10.
Human Subjects Document
IRB Approval

APPROVAL
March 19, 2024
Sahar Zangeneh
[email protected]
Dear Sahar Zangeneh:
On 3/19/2024, the IRB reviewed the following submission:
Type of Review: Initial Study
Title: Social and Economic Barriers to Receiving Optimal
Services Along the Cancer Care Continuum
Investigator: Sahar Zangeneh
IRB ID: STUDY00022733
Funding Source: CDC NCCDPHP
Customer/Client Name: CDC PGO
Project/Proposal Number: 0213618.047.000.001
Contract/Grant Number: 200-2013-M-53964B
IND, IDE, or HDE: None
The IRB approved the study on 3/19/2024. Any changes to the approved study protocol
or documents must be submitted to the IRB as a modification for review and approval
prior to implementation. Within 30 days of study completion, you should request to close
the study in IRB Express. You can submit a modification or study closure by navigating
to the active study and clicking Create Modification / CR.
In conducting this protocol, you are required to follow the requirements listed in the
Investigator Manual (HRP-103), which can be found by navigating to the IRB Library
within the IRB system.
Sincerely,
The RTI Office of Research Protection

Page 1 of 1